Skip to main content

Articles

Mirvaso (Brimonidine): First Topical Gel Approved by the FDA for the Treatment of Facial Erythema of Rosacea

Rosacea: The Patients Pay the Price

Conference Correspondent

Corticosteroid Use Reduced across 52 Weeks of Belimumab Therapy in Patients with Lupus: Combined Analyses from the BLISS Trials

Conference Correspondent

Belimumab Shows Clinical Response and Sustained Reductions in Circulating B Cells and in IgG Levels in Patients with Lupus

Conference Correspondent

Postmarketing Experience with Belimumab in Patients with Lupus in Clinical Practice Settings Confirms the Evidence from Clinical Trials

Conference Correspondent

High Levels of Interferon Type I in Plasma of Patients with Lupus Predict Future Renal Disease

Conference Correspondent

Biomarkers that Predict Development or Worsening of Lupus Nephritis in Patients with Systemic Lupus Erythematosus

Conference Correspondent

Can MDHAQ/RAPID3 Be Used in Usual Care of Patients with Systemic Lupus Erythematosus?

Conference Correspondent

Exploring a Novel Therapeutic Target in a Murine Model of Systemic Lupus Erythematosus: Targeting Sphingosine-1-Phosphate Receptors

Conference Correspondent

Serious Infections among Patients with Lupus Who Receive Corticosteroids and Immunosuppressants

Page 163 of 244
Results 1621 - 1630 of 2434